- Papers in database
- 4
- Primary author
- 1 paper
- Years active
- 2011 – 2017
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (4)
- 2017Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults10.3389/fimmu.2017.00655
- 2016Primary authorA Double‐Blind, Randomized Human Trial To Evaluate The Safety, Tolerability, And Host Response To Lactobacillus johnsonii N6.210.1096/fasebj.30.1_supplement.lb299
- 2013Lactobacillus johnsonii inhibits indoleamine 2,3‐dioxygenase and alters tryptophan metabolite levels in BioBreeding rats10.1096/fj.12-223339
- 2011Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats.10.3945/jn.110.135517